BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33905594)

  • 1. Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis.
    Rössler U; Hennig AF; Stelzer N; Bose S; Kopp J; Søe K; Cyganek L; Zifarelli G; Ali S; von der Hagen M; Strässler ET; Hahn G; Pusch M; Stauber T; Izsvák Z; Gossen M; Stachelscheid H; Kornak U
    J Bone Miner Res; 2021 Aug; 36(8):1621-1635. PubMed ID: 33905594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis.
    Hennig AF; Rössler U; Boiti F; von der Hagen M; Gossen M; Kornak U; Stachelscheid H
    Stem Cell Res; 2019 Mar; 35():101367. PubMed ID: 30763735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.
    Stauber T; Wartosch L; Vishnolia S; Schulz A; Kornak U
    Bone; 2023 Mar; 168():116639. PubMed ID: 36513280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC-7 Mutants.
    Di Zanni E; Palagano E; Lagostena L; Strina D; Rehman A; Abinun M; De Somer L; Martire B; Brown J; Kariminejad A; Balasubramaniam S; Baynam G; Gurrieri F; Pisanti MA; De Maggio I; Abboud MR; Chiesa R; Burren CP; Villa A; Sobacchi C; Picollo A
    J Bone Miner Res; 2021 Mar; 36(3):531-545. PubMed ID: 33125761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.
    Supanchart C; Wartosch L; Schlack C; Kühnisch J; Felsenberg D; Fuhrmann JC; de Vernejoul MC; Jentsch TJ; Kornak U
    Bone; 2014 Jan; 58():92-102. PubMed ID: 24103576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene.
    Hofstaetter JG; Atkins GJ; Kato H; Kogawa M; Blouin S; Misof BM; Roschger P; Evdokiou A; Yang D; Solomon LB; Findlay DM; Ito N
    Calcif Tissue Int; 2022 Oct; 111(4):430-444. PubMed ID: 35618777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients.
    Pang Q; Chi Y; Zhao Z; Xing X; Li M; Wang O; Jiang Y; Liao R; Sun Y; Dong J; Xia W
    Osteoporos Int; 2016 Mar; 27(3):1047-1055. PubMed ID: 26395888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K; Snyder R; Econs MJ
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival in infantile malignant autosomal recessive osteopetrosis secondary to homozygous p.Arg526Gln mutation in CLCN7.
    Kantaputra PN; Thawanaphong S; Issarangporn W; Klangsinsirikul P; Ohazama A; Sharpe P; Supanchart C
    Am J Med Genet A; 2012 Apr; 158A(4):909-16. PubMed ID: 22419446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.
    Del Fattore A; Peruzzi B; Rucci N; Recchia I; Cappariello A; Longo M; Fortunati D; Ballanti P; Iacobini M; Luciani M; Devito R; Pinto R; Caniglia M; Lanino E; Messina C; Cesaro S; Letizia C; Bianchini G; Fryssira H; Grabowski P; Shaw N; Bishop N; Hughes D; Kapur RP; Datta HK; Taranta A; Fornari R; Migliaccio S; Teti A
    J Med Genet; 2006 Apr; 43(4):315-25. PubMed ID: 16118345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations of TCIRG1 cause a malignant and mild phenotype of autosomal recessive osteopetrosis (ARO) in four Chinese families.
    Zhang XY; He JW; Fu WZ; Wang C; Zhang ZL
    Acta Pharmacol Sin; 2017 Nov; 38(11):1456-1465. PubMed ID: 28816234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis.
    Besbas N; Draaken M; Ludwig M; Deren O; Orhan D; Bilginer Y; Ozaltin F
    Eur J Pediatr; 2009 Dec; 168(12):1449-54. PubMed ID: 19238435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two novel mutations on CLCN7 gene in a patient with malignant ostopetrosis.
    Bonapace G; Moricca MT; Talarico V; Graziano F; Pensabene L; Miniero R
    Ital J Pediatr; 2014 Nov; 40():90. PubMed ID: 25410126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult Osteosclerotic Metaphyseal Dysplasia With Progressive Osteonecrosis of the Jaws and Abnormal Bone Resorption Pattern Due to a LRRK1 Splice Site Mutation.
    Howaldt A; Hennig AF; Rolvien T; Rössler U; Stelzer N; Knaus A; Böttger S; Zustin J; Geißler S; Oheim R; Amling M; Howaldt HP; Kornak U
    J Bone Miner Res; 2020 Jul; 35(7):1322-1332. PubMed ID: 32119750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl
    Bose S; de Heus C; Kennedy ME; Wang F; Jentsch TJ; Klumperman J; Stauber T
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.
    Henriksen K; Gram J; Schaller S; Dahl BH; Dziegiel MH; Bollerslev J; Karsdal MA
    Am J Pathol; 2004 May; 164(5):1537-45. PubMed ID: 15111300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopetrosis: genetics, treatment and new insights into osteoclast function.
    Sobacchi C; Schulz A; Coxon FP; Villa A; Helfrich MH
    Nat Rev Endocrinol; 2013 Sep; 9(9):522-36. PubMed ID: 23877423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.
    Chen W; Twaroski K; Eide C; Riddle MJ; Orchard PJ; Tolar J
    J Bone Joint Surg Am; 2019 Nov; 101(21):1939-1947. PubMed ID: 31567691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A missense mutation accelerating the gating of the lysosomal Cl-/H+-exchanger ClC-7/Ostm1 causes osteopetrosis with gingival hamartomas in cattle.
    Sartelet A; Stauber T; Coppieters W; Ludwig CF; Fasquelle C; Druet T; Zhang Z; Ahariz N; Cambisano N; Jentsch TJ; Charlier C
    Dis Model Mech; 2014 Jan; 7(1):119-28. PubMed ID: 24159188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis.
    Maranda B; Chabot G; Décarie JC; Pata M; Azeddine B; Moreau A; Vacher J
    J Bone Miner Res; 2008 Feb; 23(2):296-300. PubMed ID: 17922613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.